A blood test, combined with an ultrathin material derived from graphite, could significantly advance efforts to detect ...

The trial seeks to find an easier and less expensive way to detect a disease that affects 1 in 9 people over the age of 65.

As scientists race to develop simple blood tests that could one day act as an early warning system for Alzheimer’s disease by sounding the alarm before memory problems appear, new research shows ...

Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces challenges in uptake and education. Multistakeholder partnerships and ...

TORONTO — An expert panel convened by the Alzheimer’s Association has released the first clinical guidelines to help clinicians choose the most appropriate blood-based biomarker (BBM) test to aid in ...

Earlier this month, the FDA approved another biomarker to help millions of patients and families affected by Alzheimer’s disease: a blood test that detects amyloid plaques, a hallmark of the disease.